Statistics for Foghorn Therapeutics (id:6659 FHTX)

Valuation metrics

Market cap

436.96M

Enterprise value

208.64M

Trailing P/E (ttm)

-3.35

Forward P/E

-4.97

PEG ratio

-4.97

Price/Sales (ttm)

17.13

Price/Book (mrq)

-17.35

Enterprise Value/Revenue

8.18

Enterprise Value/EBITDA

-2.12

Overview

Shares outstanding

55.59M

Float

26.15M

Shares short

1.13M

% Held by insiders

0.19%

% Held by institutions

0.72%

Average volume (10 days)

138.25K

Average volume (90 days)

Price summary

52-Week low

2.70

52-Week high

10.25

52-Week change

44.52%

Beta

3.15

50-Day moving average

8.50

200-Day moving average

6.79

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-305.48%

Operational effectiveness

Return on assets

-20.45%

Return on equity

127.51%

Income statement

Revenue (ttm)

0.51

Revenue per share (ttm)

0.51

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-98,527,000.00

Net income to common (ttm)

-91,223,000.00

Diluted EPS (ttm)

-1.85

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

267.40M

Total cash per share (mrq)

4.81

Total debt (mrq)

39.07M

Total Debt/Equity (mrq)

-1.38

Current ratio (mrq)

477.30%

Book value per share (mrq)

-0.51

Cash flow

Cash flow statement

-103,428,000.00

Levered free cash flow (LFCF)

-42,247,248.00